GSK PLC's ticker is and the CUSIP is 37733W204. A total of 715 filers reported holding GSK PLC in Q3 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $26,141 | -87.1% | 679 | -85.7% | 0.00% | -88.9% |
| Q1 2024 | $202,946 | +103.0% | 4,734 | +75.5% | 0.01% | +50.0% |
| Q4 2023 | $99,987 | +1.8% | 2,698 | -0.4% | 0.01% | -14.3% |
| Q3 2023 | $98,201 | +2.1% | 2,709 | +0.4% | 0.01% | +16.7% |
| Q2 2023 | $96,156 | +0.2% | 2,698 | 0.0% | 0.01% | -14.3% |
| Q1 2023 | $95,994 | +1265.9% | 2,698 | +1249.0% | 0.01% | +600.0% |
| Q4 2022 | $7,028 | -49.8% | 200 | -58.3% | 0.00% | 0.0% |
| Q3 2022 | $14,000 | -46.2% | 480 | -20.0% | 0.00% | -66.7% |
| Q2 2022 | $26,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 12,340,190 | $457,759 | 41.36% |
| Eversept Partners, LP | 2,972,954 | $110,177,675 | 9.68% |
| Soleus Capital Management, L.P. | 1,278,540 | $47,382,692 | 5.26% |
| CANTOR FITZGERALD, L. P. | 638,657 | $23,668,628 | 4.86% |
| Sio Capital Management, LLC | 571,391 | $21,175,750 | 4.82% |
| Callodine Capital Management, LP | 450,000 | $16,677,000 | 4.39% |
| EQUITY INVESTMENT CORP | 3,243,259 | $120,195,186 | 3.38% |
| Clean Yield Group | 213,431 | $7,909,753 | 3.33% |
| Robinson Value Management, Ltd. | 128,079 | $4,746,608 | 3.12% |
| Hillman Capital Management, Inc. | 233,386 | $8,649,285 | 2.99% |